GABAPENTIN
- Product NDC
- 68788-7135
- 11-digit product format
- 687887135
- Labeler code
- 68788
- Product ID
- 68788-7135_b5d71771-f1aa-435f-bfaa-68b3288d51cf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA090007
- Marketing category
- ANDA
- Marketing start
- 2020-06-02
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7135-1 | 68788713501 | 100 CAPSULE in 1 BOTTLE (68788-7135-1) | 100 capsule | 2020-06-02 | 0000-00-00 | No | No | Current |
| 68788-7135-3 | 68788713503 | 30 CAPSULE in 1 BOTTLE (68788-7135-3) | 30 capsule | 2020-06-02 | 0000-00-00 | No | No | Current |
| 68788-7135-6 | 68788713506 | 60 CAPSULE in 1 BOTTLE (68788-7135-6) | 60 capsule | 2020-06-02 | 0000-00-00 | No | No | Current |
| 68788-7135-8 | 68788713508 | 120 CAPSULE in 1 BOTTLE (68788-7135-8) | 120 capsule | 2020-06-02 | 0000-00-00 | No | No | Current |
| 68788-7135-9 | 68788713509 | 90 CAPSULE in 1 BOTTLE (68788-7135-9) | 90 capsule | 2020-06-02 | 0000-00-00 | No | No | Current |